News

AstraZeneca Wainua Heart Drug Trial Fails To Meet Phase III Goal

The British drugmaker AstraZeneca announced that its late-stage clinical trial evaluating Wainua for a rare heart condition failed to meet its primary …

Novo Nordisk Eyes Rapid TGA Approval for Wegovy Weight Loss Pill in Australia

Danish pharmaceutical giant Novo Nordisk has officially identified Australia as a high-priority global market for its highly anticipated weight loss pill Wegovy. …

Sino Biopharmaceutical Respiratory Drug Deals with AstraZeneca & GSK Expand Global Reach

China’s Sino Biopharmaceutical has secured two massive international agreements with AstraZeneca and GSK for respiratory medicine. With the Sino Biopharmaceutical respiratory drug …

Vera's Trutakna Drug Gets FDA Approval For Primary IgA Nephropathy

In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney drug. Manufactured …

Breakthrough In Early Endometriosis Diagnosis: A Simple Blood Test Approved by the NHS

In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect endometriosis with …

Vertex Pharmaceuticals Acquisition of Crinetics: $10B Spend To Strengthen Rare Disease Pipeline

Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever. This massive …

Novartis Myricx Bio Acquisition: $1.5B Deal Expands Next-Generation ADC Cancer Innovation

The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition is valued …

Wegovy Weight Loss Pill In UK Is Now Available But Not In NHS

The daily Wegovy weight loss pill in UK pharmacies is now officially available through private channels following its recent regulatory clearance. The …

Legionnaires' Disease Outbreak in NYC: 14 Cases Confirmed

A recent Legionnaires’ disease outbreak in NYC has now escalated to 14 confirmed cases, up from just two cases reported early last …

Insilico Medicine Takeda Partnership

The biotechnology leader Insilico Medicine announced a major strategic collaboration with global pharmaceutical giant Takeda. This Insilico Medicine Takeda partnership aims to …

Utz Potato Chip Recall Upgraded to FDA Class I Risk Level

The U.S. Food and Drug Administration (FDA) has officially upgraded the voluntary Utz potato chip recall to the highest risk level with …

Lactalis fined for misleading claims

The Australian Competition and Consumer Commission (ACCC) has taken decisive enforcement action against Lactalis Australia Pty Ltd, a major player in the …